FMP

FMP

Enter

AMTI - Applied Molecul...

photo-url-https://images.financialmodelingprep.com/symbol/AMTI.png

Applied Molecular Transport Inc.

AMTI

NASDAQ

Inactive Equity

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.

0.263 USD

-0.0085 (-3.23%)

Historical Prices

From:

To:

We are unable to load the chart at this time.

fmp-logo

About

ceo

Mr. Shawn M. Cross

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and...

CIK

0001801777

ISIN

US03824M1099

CUSIP

03824M109

Address

450 East Jamie Court

Phone

650 392 0420

Country

US

Employee

13

IPO Date

Jun 5, 2020

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

AMTI Financial Summary

CIK

0001801777

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

03824M109

ISIN

US03824M1099

Country

US

Price

0.26

Beta

2.29

Volume Avg.

320.19k

Market Cap

11.01M

Shares

-

52-Week

0.1343-0.84

DCF

0.64

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.14

P/B

-

Website

https://www.appliedmt.com

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

Latest AMTI News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep